Endurant Capital Management’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-31,100
Closed -$365K 81
2017
Q4
$365K Buy
+31,100
New +$365K 0.11% 73